Our Client is seeking a highly motivated and team-oriented candidate for th=
e position of Scientist in the Drug Metabolism and Pharmacokinetics (DMPK) =
Department. The successful applicant will lead the development, validation,=
and application of cell based in vitro ADME assays to support our discover=
y and development programs. Reporting directly to the Senior Director of Cl=
in Pharm, this is a unique opportunity to take on a role with a broad range=
of responsibilities and work in DMPK and Clinical Pharmacology.
Core responsibilities:
Utilize animal models, define efficacy, pharmacodynamics and translational =
principles for selection of development candidate molecules Conducts the an=
alysis, interpretation and reporting of clinical and non-clinical pharmacok=
inetic data.
Helps plan, conducts and reports quantitative analyses to select / optimize=
doses, dosage regimens throughout clinical drug development Experience wit=
h Simcyp, Monolix, Phoenix Winnonlin or other modeling software. PBPK exper=
ience and experience with DDI is crucial
Qualifications:
Must have 2+ years of experience in the pharma/ biotechnology industry or P=
ost Doc. Ph.D./PharmD in Pharmacology, Biomedical Sciences, Pharmacokinetic=
s or other discipline with appropriate experience Strong, demonstrable trac=
k record of scientific leadership excellence Demonstrated small molecule dr=
ug discovery experience: track-record of advancing multiple novel therapeut=
ic agents from discovery into preclinical and subsequent clinical developme=
nt as project team leader or member Experience in successfully selecting an=
d managing CROs to provide high quality, timely and on-budget studies
For more information please contact:
TJ Elder
Search Consultant
Pre-Clinical Development
O: 413.458.6124
C: 413.207.7676
https://www.linkedin.com/in/tjelder/
telder
[cid:image001.png
Please Note:
The information in this e-mail message is legally privileged and confidenti=
al information intended only for the use of the addressee(s) named above. =
If you, the reader of this message, are not the intended recipient, you are=
hereby notified that you should not further disseminate, distribute, or fo=
rward this e-mail message. If you have received this e-mail in error, plea=
se notify the sender as soon as possible. In addition, please delete the e=
rroneously received message from any device/media where the message is stor=
ed.
Received on Mon Mar 29 2021 - 12:39:15 EDT
